NEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported profit of $10 million in its fourth quarter.

The New York-based company said it had net income of 24 cents per share. Losses, adjusted for non-recurring gains, were 6 cents per share.

For the year, the company reported profit of $64.1 million, or $1.50 per share. Revenue was reported as $2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORMP at https://www.zacks.com/ap/ORMP